SEC Form 4 · accession 0001209191-17-018468
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pat Cotroneo
Officer — VP, Finance and CFO
Period of report
Mar 1, 2017
Accepted (ET)
Mar 6, 2017 · 6:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 1, 2017 | M | 900 | $2.35 | A | 133,148 | D | |
| Common StockF1 | Mar 1, 2017 | S | 900 | $26.00 | D | 132,248 | D | |
| Common Stock | Mar 2, 2017 | M | 5,600 | $2.35 | A | 137,848 | D | |
| Common StockF1 | Mar 2, 2017 | S | 5,600 | $26.00 | D | 132,248 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.35 | Mar 1, 2017 | M | 900 | D | — | Mar 12, 2018 | Common Stock | 900 | 17,600 | D |
| Stock Option (Right to Buy)F2 | $2.35 | Mar 2, 2017 | M | 5,600 | D | — | Mar 12, 2018 | Common Stock | 5,600 | 12,000 | D |
Explanation of responses
- F1Shares sold pursuant to a 10b5-1 plan.
- F2Fully vested.